[WEBINAR] COVID-19 Clinical Update with Professor David Wilkinson (Week 6)

As the COVID-19 situation develops, Professor David Wilkinson presents the sixth webinar in our ongoing series to provide an informed clinical update and advice for GPs. Prof Wilkinson is the Deputy Vice-Chancellor at Macquarie University, as well as a general practitioner, public health medicine specialist and epidemiologist. He gathers details every day from resources available to few, so that he can put together a presentation that is unique from any other COVID-19 information out there.

Some of the topics covered in this webinar include:

  • The current statistics in Australia
  • What’s happening around the world, especially in treatments?
  • How effective is the lockdown approach?
  • What is the plan going forward?
  • Implications for the control of asymptomatic infection
  • A fascinating case study of an outbreak in a nursing facility in the US

We are here to support medical professionals facing these challenging circumstances. Each week, we will hold two webinars + Q&A with expert guidance to assist you in navigating this evolving international public health situation from a clinical and business point of view.

Watch the full webinar recording now:

Join us live for next week’s COVID-19 webinar or receive the recording by registering here.


Questions addressed by Professor Wilkinson during the webinar:

  • I have come across some grave concerns expressed by Intensive Care Specialists in the US in regards the unpredictability and serious multi-organ disease that COVID-19 can cause in infected individuals – thrombi and emboli in particular.
  • What are your thoughts on the easing of restrictions here in Australia, in light of the fact that a vaccine is many months away at best, and the inevitable second wave however small or large will result in more positive cases?
  • All this at a time when we still know little to nothing about how to actively treat infected individuals? Support is the best ’treatment’ there is.
  • Is there any evidence the virus is more active at colder temperatures? I.e. any implications for winter other than comorbidities like flu?
  • I heard dermatological signs like erythematous maculopapular rash present in big toes is one of signs in COVID-19 cases. Is this right?
  • I heard it is a man-made virus like biological weapons. What’s your opinion about it?
  • Once again may we obtain a copy of this presentation? Also was the plasma treatment proposed in pooled area or does it have to be HLA compatible?
  • Are we going to see a lot more numbers of long-term adverse clinical outcomes for positive cases apart from deaths?

Leave a Reply

Your email address will not be published. Required fields are marked *